Series A startup

Who invested in Syrrx

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$5.1Mraised across 1 round since 2000, from 1 source

Latest round
Series A, $5.1MAug 2000
Investors
4
See who backed them

The rounds

  1. Aug 2000
    Series A$5.1M

    From a historical funding record

The exit

ExitBuyerPriceWhen
AcquiredTakeda Pharmaceutical$270MFeb 2005

From historical deal records. Wrong? Tell us.

Everyone who backed them

Versant VenturesVC firm1round
MPM CapitalPrivate equity1round
CMEA VenturesVC firm1round
Bay City CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Syrrx

Who invested in Syrrx?

Syrrx's investors include Versant Ventures, MPM Capital, CMEA Ventures and Bay City Capital.

How much has Syrrx raised?

Syrrx has raised $5.1M across 1 round since 2000.

When did Syrrx last raise?

Syrrx's most recent round was a Series A of $5.1M in Aug 2000.

What was Syrrx's biggest round?

Its most recent round, $5.1M in Aug 2000, is also its largest on record.

Who backed Syrrx first?

Syrrx's first round on record, in Aug 2000, was backed by Versant Ventures, MPM Capital and CMEA Ventures and 1 others.

What stage is Syrrx at?

Syrrx's latest named round is a Series A, in Aug 2000.

Companies like Syrrx

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.